<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03542864</url>
  </required_header>
  <id_info>
    <org_study_id>BCE26418</org_study_id>
    <nct_id>NCT03542864</nct_id>
  </id_info>
  <brief_title>Medical Supervised Duodenal-Enteral Feeding Treatment</brief_title>
  <official_title>Medical Supervised Duodenal-Enteral Feeding for Overweight, Obesity and Increased Body Fat Percentage Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BiomediKcal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Alicante</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universidad Miguel Hernandez de Elche</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>BiomediKcal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Medical Supervised Duodenal-Enteral Feeding for Overweight, Obesity and Increased Body Fat
      Percentage Treatment based on an intervention procedure performed by a Licensed Nutritionist
      Doctor for weight loss and loss of fat percentage in patients who need it.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Medical Supervised Duodenal-Enteral Feeding for Overweight, Obesity and Increased Body Fat
      Percentage Treatment based on an intervention procedure performed by a Licensed Nutritionist
      Doctor for weight loss and loss of fat percentage in patients who need it. The feeding is by
      nasogastric-duodenal tube depending on the desired fat loss and / or weight in relation to
      the basal metabolism. Feeding by tube of 12-29 days, continuing with personalized nutritional
      treatment for 2 weeks and physical activity during the protocol. Losses of weight and / or
      expected fat greater than 10%. The results will be compared with bariatric surgery. The main
      objective is to provide a tool for the obesity epidemic that can be applied worldwide by
      doctors without the complications of surgery and with a lower price for health systems and
      controlling the actions of the hormones leptin and ghrelin.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 3, 2017</start_date>
  <completion_date type="Actual">January 4, 2019</completion_date>
  <primary_completion_date type="Actual">December 23, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Duodenal-Enteral medical supervised feeding response</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weightloss</measure>
    <time_frame>Change from Baseline weight at 1 and 3 months</time_frame>
    <description>Decrease, minor difference in weight at the end of treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fat loss</measure>
    <time_frame>Change from Baseline fat percentage at 1 and 3 months</time_frame>
    <description>Decrease, minor difference in percentage of fat at the end of treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Loss of measures</measure>
    <time_frame>Change from Baseline measures at 1 and 3 months</time_frame>
    <description>Decrease of measurements in perimeters (arm, waist, hip, thigh)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Obesity</condition>
  <condition>Obesity, Visceral</condition>
  <condition>Overweight and Obesity</condition>
  <condition>Body Fat Disorder</condition>
  <condition>Feeding and Eating Disorders</condition>
  <condition>Hormone Disturbance</condition>
  <condition>Weight Loss</condition>
  <arm_group>
    <arm_group_label>Nasogastroduodenal Protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Evaluation of a protocol for the treatment of excess body fat through duodenal nutrition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Change from Baseline Body Composition values at 1 and 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Data analysis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Analysis and publication of data</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nasogastroduodenal Protocol</intervention_name>
    <description>Complete nutrition (carbohydrates, lipids, proteins, vitamins, oligoelements)</description>
    <arm_group_label>Nasogastroduodenal Protocol</arm_group_label>
    <other_name>Medical-Clinical-Nutrition assessment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Progress registration of body composition values</description>
    <arm_group_label>Controls</arm_group_label>
    <other_name>Progress</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data analysis</intervention_name>
    <description>Statistical analysis of all data</description>
    <arm_group_label>Data analysis</arm_group_label>
    <other_name>Statistics</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Desire for weight loss, desire to improve body image, voluntariness

        Exclusion Criteria:

        - esophageal alteration or swallowing, not sign the informed consent, acute active disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isaac Kuzmar, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>BiomediKcal - Advanced Medical Nutrition &amp; Lifestyle Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>BiomediKcal - Advanced Medical Nutrition &amp; Lifestyle Center</name>
      <address>
        <city>Barranquilla</city>
        <state>Atlantico</state>
        <zip>080020</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <results_reference>
    <citation>Kuzmar I, Rizo M, Cortés-Castell E. Adherence to an overweight and obesity treatment: how to motivate a patient? PeerJ. 2014 Jul 29;2:e495. doi: 10.7717/peerj.495. eCollection 2014.</citation>
    <PMID>25101227</PMID>
  </results_reference>
  <results_reference>
    <citation>Carey DG, Pliego GJ, Raymond RL, Skau KB. Body composition and metabolic changes following bariatric surgery: effects on fat mass, lean mass and basal metabolic rate. Obes Surg. 2006 Apr;16(4):469-77.</citation>
    <PMID>16608613</PMID>
  </results_reference>
  <results_reference>
    <citation>Carey DG, Pliego GJ, Raymond RL. Body composition and metabolic changes following bariatric surgery: effects on fat mass, lean mass and basal metabolic rate: six months to one-year follow-up. Obes Surg. 2006 Dec;16(12):1602-8.</citation>
    <PMID>17217636</PMID>
  </results_reference>
  <results_reference>
    <citation>Kuzmar I, Cortés E, Rizo M. Age group, menarche and regularity of menstrual cycles as efficiency predictors in the treatment of overweight. Nutr Hosp. 2014 Oct 30;31(2):637-41. doi: 10.3305/nh.2015.31.2.7501.</citation>
    <PMID>25617544</PMID>
  </results_reference>
  <results_reference>
    <citation>Strain GW, Gagner M, Inabnet WB, Dakin G, Pomp A. Comparison of effects of gastric bypass and biliopancreatic diversion with duodenal switch on weight loss and body composition 1-2 years after surgery. Surg Obes Relat Dis. 2007 Jan-Feb;3(1):31-6. Epub 2006 Nov 20.</citation>
    <PMID>17116424</PMID>
  </results_reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>April 26, 2018</study_first_submitted>
  <study_first_submitted_qc>May 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2018</study_first_posted>
  <last_update_submitted>July 9, 2019</last_update_submitted>
  <last_update_submitted_qc>July 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>BiomediKcal</investigator_affiliation>
    <investigator_full_name>Isaac Kuzmar, MD, MBT, MsCN, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>overweight</keyword>
  <keyword>fat percentage</keyword>
  <keyword>body fat</keyword>
  <keyword>enteral feeding</keyword>
  <keyword>fat loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity, Abdominal</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
    <mesh_term>Feeding and Eating Disorders</mesh_term>
    <mesh_term>Endocrine System Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Only available for scientific journal review process</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

